| Heart disease and stroke statistics—2014 update: a report from the American Heart Association AS Go, D Mozaffarian, VL Roger, EJ Benjamin, JD Berry, MJ Blaha, S Dai, ... circulation 129 (3), e28-e292, 2014 | 50585* | 2014 |
| Heart disease and stroke statistics—2016 update: a report from the American Heart Association D Mozaffarian, EJ Benjamin, AS Go, DK Arnett, MJ Blaha, M Cushman, ... circulation 133 (4), e38-e360, 2016 | 28708* | 2016 |
| COVID-19 and its implications for thrombosis and anticoagulation JM Connors, JH Levy Blood, The Journal of the American Society of Hematology 135 (23), 2033-2040, 2020 | 2679 | 2020 |
| Idarucizumab for dabigatran reversal CV Pollack Jr, PA Reilly, J Eikelboom, S Glund, P Verhamme, ... New England Journal of Medicine 373 (6), 511-520, 2015 | 2055 | 2015 |
| Coagulation abnormalities and thrombosis in patients with COVID-19 M Levi, J Thachil, T Iba, JH Levy The Lancet Haematology 7 (6), e438-e440, 2020 | 1735 | 2020 |
| The risk associated with aprotinin in cardiac surgery DT Mangano, IC Tudor, C Dietzel New England Journal of Medicine 354 (4), 353-365, 2006 | 1369 | 2006 |
| Coagulopathy in COVID‐19 T Iba, JH Levy, M Levi, J Thachil Journal of thrombosis and haemostasis 18 (9), 2103-2109, 2020 | 1300* | 2020 |
| Idarucizumab for dabigatran reversal—full cohort analysis CV Pollack Jr, PA Reilly, J Van Ryn, JW Eikelboom, S Glund, ... New England Journal of Medicine 377 (5), 431-441, 2017 | 1236 | 2017 |
| Guidelines for perioperative care in cardiac surgery: enhanced recovery after surgery society recommendations DT Engelman, WB Ali, JB Williams, LP Perrault, VS Reddy, RC Arora, ... JAMA surgery 154 (8), 755-766, 2019 | 913 | 2019 |
| Thromboinflammation and the hypercoagulability of COVID‐19 JM Connors, JH Levy Journal of thrombosis and haemostasis 18 (7), 1559-1561, 2020 | 816 | 2020 |
| Inflammatory response to cardiopulmonary bypass JH Levy, KA Tanaka The Annals of thoracic surgery 75 (2), S715-S720, 2003 | 801 | 2003 |
| Safety of recombinant activated factor VII in randomized clinical trials M Levi, JH Levy, HF Andersen, D Truloff New England Journal of Medicine 363 (19), 1791-1800, 2010 | 795 | 2010 |
| Scientific and standardization committee communication: clinical guidance on the diagnosis, prevention, and treatment of venous thromboembolism in hospitalized patients with … AC Spyropoulos, JH Levy, W Ageno, JM Connors, BJ Hunt, T Iba, M Levi, ... Journal of Thrombosis and Haemostasis 18 (8), 1859-1865, 2020 | 791* | 2020 |
| Patient blood management: recommendations from the 2018 Frankfurt Consensus Conference MM Mueller, H Van Remoortel, P Meybohm, K Aranko, C Aubron, ... Jama 321 (10), 983-997, 2019 | 634 | 2019 |
| The unique characteristics of COVID-19 coagulopathy T Iba, JH Levy, JM Connors, TE Warkentin, J Thachil, M Levi Critical care 24, 1-8, 2020 | 595 | 2020 |
| Effects of red-cell storage duration on patients undergoing cardiac surgery ME Steiner, PM Ness, SF Assmann, DJ Triulzi, SR Sloan, M Delaney, ... New England Journal of Medicine 372 (15), 1419-1429, 2015 | 512 | 2015 |
| Blood coagulation: hemostasis and thrombin regulation KA Tanaka, NS Key, JH Levy Anesthesia & Analgesia 108 (5), 1433-1446, 2009 | 490 | 2009 |
| Inflammation and thrombosis: roles of neutrophils, platelets and endothelial cells and their interactions in thrombus formation during sepsis T Iba, JH Levy Journal of Thrombosis and Haemostasis 16 (2), 231-241, 2018 | 481 | 2018 |
| The coagulopathy, endotheliopathy, and vasculitis of COVID-19 T Iba, JM Connors, JH Levy Inflammation Research 69, 1181-1189, 2020 | 468 | 2020 |
| Diagnosis and management of sepsis‐induced coagulopathy and disseminated intravascular coagulation T Iba, JH Levy, TE Warkentin, J Thachil, T van der Poll, M Levi, ... Journal of Thrombosis and Haemostasis 17 (11), 1989-1994, 2019 | 440 | 2019 |
Frank Sellkebrown medical schoolbrown.edu의 이메일 확인됨